CMS will increase the equipment utilization rate assumption used to determine the practice expense for all nontherapeutic medical equipment, including diagnostic imaging systems, from 50% to 90% under new Medicare fee schedule rules announced Friday. In a bit of good news for radiology, CMS said it remains on track to require that suppliers of advanced imaging services become accredited by 2012.
CMS will increase the equipment utilization rate assumption used to determine the practice expense for expensive, nontherapeutic medical equipment, including diagnostic imaging systems, from 50% to 90% under new Medicare fee schedule rules announced Friday. In a bit of good news for radiology, CMS said it remains on track to require that suppliers of advanced imaging services become accredited by 2012.
The announced hike of the assumed utilization rate for advanced imaging equipment covered by the Medicare Physician Fee Schedule was not quite as onerous as expected. Although the utilization rate assumption for medical imaging equipment that costs more than $1 million will jump substantially, the new standard will be phased in over a four-year period.
Congress is likely to change this formula. The House reform bill announced this week would increase the assumed utilization rate for advanced imaging equipment to 75%. The Senate Finance Committee bill proposes a 65% utilization rate.
The 2010 Medicare fee schedule rules reflect important gains made by organized radiology in the Medicare Improvements for Patients and Providers Act of 2008. In deference to the law, the 2010 fee schedule states that CMS will implement a requirement that suppliers of the technical component of advanced imaging services must become accredited by Jan. 1, 2012.
The accreditation requirement will apply to mobile units, physicians' offices, and independent diagnostic testing facilities that perform diagnostic imaging, but would exempt physicians who interpret it. The rule states that CMS will address suppliers' accountability, business integrity, physician and technologist training, service quality, and performance management in future communications.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
FDA Clears Mobile C-Arm Device that May Accelerate Fluoroscopic and 3D CT Imaging
March 21st 2024Offering ease of mobility and self-driving capabilities, the Ciartic Move C-arm device reportedly reduces the stress and potential for error associated with manual repositioning during intraoperative imaging with computed tomography and fluoroscopy.